Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Exclusivamente para uso en investigacin de laboratorio
John Rush has received consulting fees from Compass Inc., Curbstone Consultant LLC, Emmes Corp., Evecxia Therapeutics, Inc., Holmusk Technologies, Inc., ICON, PLC, Johnson and Johnson (Janssen), Liva-Nova, MindStreet, Inc., Neurocrine Biosciences Inc., Otsuka-US
Achieve your goal body weight, improve your health, and boost your confidence with our proven weight loss program in Scottsdale
Anti-tumor activity of the type I PRMT inhibitor, GSK3368715, synergizes with PRMT5 inhibition through MTAP loss
US$ 27.15
US$ 28.41
US$ 22.45
US$ 20.43
